Pulmonary hypertension in canine degenerative mitral valve disease
Authors:
- Heidi B. KellihanHKHeidi B. Kellihan
- Rebecca L. StepienRSRebecca L. Stepien
- 1 March 2012
- journal article
- review article
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 14 (1) , 149-164
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- La circulación pulmonar en la insuficiencia cardiacaRevista Espanola de Cardiologia, 2010
- Early increase in pulmonary vascular reactivity with overexpression of endothelin‐1 and vascular endothelial growth factor in canine experimental heart failureExperimental Physiology, 2008
- Sildenafil Citrate Therapy in 22 Dogs with Pulmonary HypertensionJournal of Veterinary Internal Medicine, 2007
- Retrospective Evaluation of Sildenafil Citrate as a Therapy for Pulmonary Hypertension in DogsJournal of Veterinary Internal Medicine, 2006
- Doppler Echocardiographic Prediction of Pulmonary Hypertension in West Highland White Terriers with Chronic Pulmonary DiseaseJournal of Veterinary Internal Medicine, 2006
- Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Chronic Heart FailureEuropean Journal of Heart Failure, 2005
- Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Role of Endogenous Endothelin in Chronic Heart FailureCirculation, 1997
- Role of Nitric Oxide in the Local Regulation of Pulmonary Vascular Resistance in HumansCirculation, 1996
- Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure.Circulation Research, 1991